Costeffectiveness of Remdesivir and Dexamethasone for COVID19 Treatment in South Africa

Youngji JoLise JamiesonIjeoma EdokaLawrence LongS SilalJ PulliamH MoultrieIan SanneGesine Meyer-RathBrooke Nichols2023-04-132023-04-13WOS2328-8957https://hdl.handle.net/10539/35026Costeffectiveness of Remdesivir and Dexamethasone for COVID19 Treatment in South Africa